DNA2.0, Inc., the leading California-based bioengineering company, announced today that it has moved its corporate headquarters from Menlo Park, CA to a new, energy efficient, environmentally friendly bioproduction facility in Newark, CA, right across the San Francisco Bay from its prior location.
“Over the last few years, DNA2.0 has experienced significant business growth. Our proprietary GPS bioengineering platform combines synthetic genes and machine learning and has been adopted by a growing number of customers in biopharmaceutical, industrial and agricultural companies for a diverse range of applications,” said Jeremy Minshull, PhD., CEO of DNA2.0. “This new facility provides us with almost 50,000 sq. ft. of custom-built laboratory space designed specifically to support our increasingly industrialized scale of bioengineering service. Since the company’s 2003 inception as a gene synthesis provider, we now have a bioengineering service platform ranging from protein expression optimization to protein engineering and bioinformatics software. Our new green facility will allow us to rapidly accelerate our expansion and better serve our customers’ needs.”
About DNA2.0:
DNA2.0 is the leading bioengineering solutions provider, offering an integrated pipeline of solutions including gene design, optimization and synthesis, expression vectors, and platforms for protein and strain engineering. DNA2.0 explores novel applications for synthetic genes and the synergy between efficient gene design and protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. The company is privately held and is headquartered in Newark, California. For more information, please visit www.DNA20.com.